Neuropathy-specific alterations in a Mexican population of diabetic patients

• Published in: BMC neurology 2017-08, Vol.17 (1), p.161-161, Article 161
• Main Authors: Carbajal-Ramírez, Angélica, García-Macedo, Rebeca, Díaz-García, Carlos Manlio, Sanchez-Soto, Carmen, Padrón, Araceli Méndez, de la Peña, Jorge Escobedo, Cruz, Miguel, Hiriart, Marcia
• Format: Article
• Language: English
• Subjects: Analysis; Cardiovascular complications; Cell adhesion; Cell adhesion molecules; Chronic illnesses; Cross-Sectional Studies; Cytokines; Diabetes; Diabetes mellitus; Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - epidemiology; Diabetic complications; Diabetic Neuropathies - blood; Diabetic Neuropathies - epidemiology; Diabetic neuropathy; Diabetic retinopathy; Diabetics; Dyslipidemia; E-selectin; Growth factors; Health aspects; Humans; Indians, North American - statistics & numerical data; Inflammation; Insulin resistance; Interleukin 10; Interleukin 6; Interleukin-10 - blood; Interleukin-6 - blood; Kidney function tests; Medicine; Metabolic disorders; Metabolism; Mexico; Motor task performance; Nerve growth factor; Nerve Growth Factor - blood; Pain; Peripheral nerve diseases; Peripheral neuropathy; Polyneuropathy; Population; Renal function; Tumor necrosis factor-TNF
• ISSN: 1471-2377; 1471-2377
• DOI: 10.1186/s12883-017-0939-6

Neuropathy is one of the major complications of type 2 diabetes mellitus. Our first aim was to determine the clinical characteristics of a population of diabetic patients with different types of neuropathy. Our next goal was to characterize the cytokine profile (IL-6 and IL-10), nerve growth factor (NGF) and circulating cell-adhesion molecules in these patients. Finally, we aimed to compare the renal function among the groups of neuropathic patients. In a cross-sectional study, we included 217 diabetic patients classified in three groups: sensory polyneuropathy with hypoesthesia (DS P) or hyperesthesia (DS P), and motor neuropathy (DMN). Two control groups were included: one of 26 diabetic non-neuropathic patients (DNN), and the other of 375 non-diabetic (ND) healthy subjects. The participants were attending to the Mexican Institute of Social Security. The circulating levels of NGF were significantly lower in diabetic patients, compared to healthy subjects. The range of IL-6 and IL-10 levels in neuropathic patients was higher than the control groups; however, several samples yielded null measurements. Neuropathic patients also showed increased circulating levels of the adhesion molecules ICAM, VCAM, and E-Selectin, compared to the ND group. Moreover, neuropathic patients showed reduced glomerular filtration rates compared to healthy subjects (82-103 ml/min per 1.73 m , data as range from 25th-75th percentiles), especially in the group with DMN (45-76 ml/min per 1.73 m ). Some particular alterations in neuropathic patients included -but were not limited to- changes in circulating NGF, cell adhesion molecules, inflammation, and the worsening of the renal function. This study supports the need for further clinical surveillance and interventions considering a neuropathy-related basis.